Basic Information
Medra is building the world's first end-to-end physical artificial intelligence scientist platform to achieve continuous experimentation. By combining AI-driven scientific reasoning, robotic execution, and real-time optimization, Medra has established a new paradigm for drug discovery, capable of continuously learning, scaling, and predicting therapeutic success at every stage of development.
Medra
SanFrancisco,California,United States of America
15~50 people
January 01, 2021
--

